Ocular Therapeutix, Inc. (OCUL)
8.07
-0.42
(-4.95%)
USD |
NASDAQ |
Apr 06, 16:00
8.12
+0.05
(+0.62%)
After-Hours: 20:00
Ocular Therapeutix SG&A Expense (TTM) : 118.30M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| EyePoint Plc | 51.70M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Vertex Pharmaceuticals, Inc. | 1.753B |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Rhythm Pharmaceuticals, Inc. | 194.94M |